Patents Examined by Anna P. Fagelson
  • Patent number: 4220657
    Abstract: Sterile aqueous humor from patients afflicted with the disease endogenous uveitis contains a previously unreported pathogenic microorganism, Micromyces intracellularis, which also has been found in tissue specimens from other diseases. When inoculated into an animal model (e.g., a mouse), the microorganism produces both chronic eye and systemic disease in addition to accelerated mortality and occasional psychotic animal behavior, metabolic disturbances, and neuro-muscular disorders, depending on the mode of inoculation. The animal model therefore provides the basis for a screening process to evaulate chemotherapeutic agents in the treatment of human disease. Using this animal model, a significant decrease in mortality associated with the introduction of Micromyces intracellularis is achieved by the application to the animal model of the chemotherapeutic agents d-2,2'-(ethylenediimino)-di-1-butanol, 4,4'sufonyldianiline, and 3[[(4-methyl-1-piperazinyl)-imino]methyl]-rifamycin SV.
    Type: Grant
    Filed: August 11, 1978
    Date of Patent: September 2, 1980
    Inventors: Lewis A. Johnson, Emil Wirostko
  • Patent number: 4219539
    Abstract: Using anti-IgG and anti-Fc sera which is reacted with gastric cancer juice from a patient by double diffusion on Ouchterlony agarose, there is repeatedly obtained a double precipitin line. Under immunoelectrophoresis, anodic displacement of anti-IgG and anti-Fc sera is observed. The .beta..sub.1 to .alpha..sub.1 precipitin line with anti-IgG and anti-Fc is thus formed to be characteristic of gastric cancer juice. These double precipitin lines correspond to an antigen-antibody complex which are uniquely identified by Ouchterlony immunodiffusion assay with these anti-immunoglobulin sera. Only a single precipitin line is formed between gastric cancer juice and anti-Fab serum.Both with anti-IgG and anti-Fc, various lines are obtained under immunoelectrophoresis with different mobilities, from gamma to .alpha..sub.1. With anti-Fab, however, there is no displacement toward the anode. Normally, Fc seldom moves beyond the site of origin.
    Type: Grant
    Filed: February 24, 1978
    Date of Patent: August 26, 1980
    Inventor: Emmanuel Deutsch
  • Patent number: 4219568
    Abstract: Certain N,N-dialkyl substituted derivatives of dopamine (DA) increase renal blood flow without affecting cardiac contractility. Particularly effective are N,N-di-n-propyl DA; N-n-propyl-N-n-butyl DA; N-n-propyl-N-n-pentyl DA; N-n-propyl-N-isobutyl DA; and N-n-propyl-N-phenethyl DA. Orally effective versions of these derivatives are obtained by acylating the hydroxyl functions.
    Type: Grant
    Filed: March 1, 1978
    Date of Patent: August 26, 1980
    Assignee: University Patents, Inc.
    Inventors: Leon I. Goldberg, Joseph G. Cannon, John P. Long
  • Patent number: 4215130
    Abstract: Therapeutic antihypertensive compositions containing N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine and N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine or their non-toxic, pharmaceutically acceptable salts are described as well as a method of reducing blood pressure in mammals.
    Type: Grant
    Filed: May 31, 1977
    Date of Patent: July 29, 1980
    Assignee: Richardson-Merrell Inc.
    Inventor: Albert Sjoerdsma
  • Patent number: 4215106
    Abstract: A local hemostatic comprising an active principle which is the incomplete ferric salt of polyacrylic acid of the formula: ##STR1## in combination with a pharmaceutical solvent which is water or physiological solution. The active principle content is 1 to 2 percent by weight.
    Type: Grant
    Filed: April 7, 1978
    Date of Patent: July 29, 1980
    Inventors: Mikhail G. Voronkov, Ada T. Platonova, Vladislava Z. Annenkova, Galina M. Kononchuk, Valentina B. Kazimirovskaya, Galina S. Ugrjumova, Valentina M. Annenkova
  • Patent number: 4211764
    Abstract: The proposed gastric secretion stimulator comprises an active principle which is 2-amino-5-(2-aminoethyl)-1,3,4-thiadiazole, and a pharmaceutical carrier for said active principle. The stimulator is used in the form of hydrochlorides. It displays a selective stimulating effect upon H.sub.2 -ceptors of secretory cells of the stomach and produces a maximum of gastric secretion, which is an important diagnostic factor. The gastric secretion stimulator of this invention is advantageous in that besides parenteral administration, it may be administered per os.
    Type: Grant
    Filed: March 13, 1978
    Date of Patent: July 8, 1980
    Assignee: Nauchno-Issledovatelsky Institut Experimentalnoi Meditsiny
    Inventors: Leonid L. Grechishkin, Ljudmila K. Gavrovskaya, Vadim L. Goldfarb
  • Patent number: 4211766
    Abstract: A process for the isolation of cancer associated polypeptide antigen mainly by several steps of gel filtration and pH-gradient elution; a cancer associated polypeptide antigen based on a single peptide chain and denaturating irreversibly at pHs exceeding about 4.5; a composition comprising such antigen and a stabilizing amount of albumen in admixture therewith and a method of making such composition; a diagnostic composition comprising a particulate material labelled with albumen-stabilized antigen; process for preparing antibodies monospecific with regard to the cancer associated polypeptide antigen comprising preparing an oil emulsion, wherein an acid aqueous solution of the polypeptide is enclosed phase protected by a surrounding oil phase; a cancer diagnosis method based on determining the presence of cancer associated polypeptide antigen in a living animal body under examination; and composition useful as an immunizing agent containing as an active ingredient the cancer associated polypeptide antigen.
    Type: Grant
    Filed: March 30, 1979
    Date of Patent: July 8, 1980
    Assignee: AB Bonnierforetagen
    Inventor: Knut B. Bjorklund
  • Patent number: 4211770
    Abstract: Pharmaceutical composition for treatment of proliferating skin diseases, primarily psoriasis. The compositions comprise a pharmaceutical carrier with a compound of the formula ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and selected from the group consisting of benzoyl, adamantane carboxylate or an acyl radical of an aliphatic carboxylic acid having from 2 to 18 carbon atoms inclusive including the pharmacologically acceptable acid addition salts thereof as the active compound.The compositions are administered to humans and animals systemically or topically.
    Type: Grant
    Filed: November 7, 1975
    Date of Patent: July 8, 1980
    Assignee: The Upjohn Company
    Inventor: John J. Voorhees
  • Patent number: 4208402
    Abstract: A process for improving the appearance of oily hair or skin, including the scalp, comprises applying thereto an effective amount of an aqueous or hydroalcoholic solution of gelatin present in an amount of about 0.5 to 1.5 percent by weight thereof.
    Type: Grant
    Filed: January 10, 1977
    Date of Patent: June 17, 1980
    Assignee: L'Oreal
    Inventors: Pierre Bore, Lucienne Tourenq
  • Patent number: 4207337
    Abstract: New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
    Type: Grant
    Filed: November 20, 1978
    Date of Patent: June 10, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Miguel A. Ondetti, David W. Cushman
  • Patent number: 4207342
    Abstract: New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
    Type: Grant
    Filed: November 20, 1978
    Date of Patent: June 10, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Miguel A. Ondetti, David W. Cushman
  • Patent number: 4207309
    Abstract: Derivatives of phenylisoquinoline, in particular 8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydro-iso-quinoline hydrogen maleate, are used as effective agents in the differential diagnosis of disorders of hypothalamo-pituitary function. The phenylisoquinoline derivatives are administered orally at a dose of about 1-5 mg/body wt. in order to differentiate between "functional" and "organic" (tumorous) diseases.
    Type: Grant
    Filed: October 20, 1978
    Date of Patent: June 10, 1980
    Inventor: Eugenio E. Muller
  • Patent number: 4206232
    Abstract: New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
    Type: Grant
    Filed: November 20, 1978
    Date of Patent: June 3, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Miguel A. Ondetti, David W. Cushman
  • Patent number: 4201763
    Abstract: An assay method suitable for antigens (or haptens) including proteins and polypeptides utilizing antibodies for the unknown protein or polypeptide in which the antibodies are covalently bound to water insoluble hydrophylic polymeric particles. Appropriate fluorescently labeled immune reactants are introduced during the method and together with the unknown antigen are immunologically bound, directly or indirectly, to the particles for separation from the reaction liquid. The particles have a size of about 0.1-10 microns and can be resuspended for direct measurement of the fluorescent labels in a fluorometer from which the unknown can be determined.
    Type: Grant
    Filed: February 6, 1978
    Date of Patent: May 6, 1980
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: James F. Monthony, Michael W. Burgett, Robert V. Dahlstrom
  • Patent number: 4200649
    Abstract: New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
    Type: Grant
    Filed: November 20, 1978
    Date of Patent: April 29, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Miguel A. Ondetti, David W. Cushman
  • Patent number: 4199599
    Abstract: Glyceryl-tri-3,5,5-trimethylhexanoate is particularly suitable for use in cosmetic preparations, particularly in skin creams used for protection against harmful outside agents.
    Type: Grant
    Filed: February 3, 1978
    Date of Patent: April 22, 1980
    Assignee: Dragoco Gerberding & Co. GmbH
    Inventor: Erich Klein
  • Patent number: 4198389
    Abstract: A method and system for a rapid and sensitive method for determining immunologically active materials in a biological fluid by observing an antigen-antibody reaction after application of reactants on the surface of a gel matrix and applying an alternating current thereto.
    Type: Grant
    Filed: August 17, 1977
    Date of Patent: April 15, 1980
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Charles Wadsworth
  • Patent number: 4197361
    Abstract: An immunoassay for the sandwich technique is disclosed in which antibody (or antigen) is bound to a plastic strip, and after reaction with a test sample and then fluorescently tagged antibody (or antigen), fluorescense is read directly from the plastic strip in a fluorometer.
    Type: Grant
    Filed: August 23, 1977
    Date of Patent: April 8, 1980
    Assignee: Warner-Lambert
    Inventors: Gail Hoff, Lillian Robichaud
  • Patent number: 4197237
    Abstract: Nitrogen derivatives of benzoyl ecgonine and cocaine are provided, particularly amino, diazonium, and diazo derivatives, the compounds finding use either directly or as intermediates for the preparation of reagents for use in immunoassays. Diazo compounds can be coupled with antigenic materials for the preparation of antibodies to benzoyl ecgonine and/or cocaine. The amino group can be combined with active non-oxo-carbonyl compounds to form reagents which find use in immunoassays.
    Type: Grant
    Filed: February 12, 1975
    Date of Patent: April 8, 1980
    Assignee: Syva Company
    Inventors: Richard K. Leute, Gunner Bolz
  • Patent number: 4196186
    Abstract: Malignant brain tumors may be diagnosed by comparing the amounts of certain proteins bound to a product, Malignin, derived from brain tumor cells, complexed to an inert carrier, such as bromacetylcellulose.
    Type: Grant
    Filed: November 17, 1977
    Date of Patent: April 1, 1980
    Inventor: Samuel Bogoch